source
- FDA acting director of cell and gene therapies Vijay Kumar to depart his postVijay Kumar, who has been serving as the acting director of the Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products, announced he will leave his position. In an inte…
- Nominations are open for the 2026 Endpoints 11 awardsThere’s never been a higher bar for innovation than right now. Almost any promising molecule quickly has a horde of copycats. Development costs keep rising. Investors are leaning on seemingly safer…Endpoints · 1mo ago↗ source
- How mental health chatbots are trained on therapy sessionsAs people increasingly turn to AI for everyday tasks, companionship and emotional assurance, virtual mental health companies once wary of AI are racing to build out their own chatbots to stay compe…